Corning Sinks After Q1 Beat as Softer Q2 Guidance Disappoints Investors
Corning beat Q1 estimates but gave weak Q2 outlook, so shares fell despite strong year-to-date gains.
Already have an account? Sign in.
Corning beat Q1 estimates but gave weak Q2 outlook, so shares fell despite strong year-to-date gains.
Abivax shares fell after Scorpion Capital claimed its ulcerative colitis drug is toxic. The company rejected the report and reaffirmed its Phase 3 data.
CrowdStrike is reportedly in talks to acquire Zscaler in a potential $265 billion cybersecurity deal, one of the largest in the sector.
Canadian Solar shares fell sharply after a report that the solar firm and its Recurrent Energy unit are considering asset sales and a possible Chapter 11 filing.
Be the first to know when deals break, stocks move, or biotech headlines hit.